SBU News
SBU News > Newsroom > Featured Press Story > Targeting K17 in Pancreatic Cancer

Targeting K17 in Pancreatic Cancer

Shroyerkenneth

Targeting K17 in Pancreatic Cancer

Drs. Kenneth Shroyer and Luisa Escobar-Hoyos receive $500,000 from PanCAN to advance research

Shroyer
Kenneth Shroyer, MD, PhD

STONY BROOK, N.Y., June 27, 2018 – Keratin 17 (K17), a protein that promotes cancer, may prove to be a key target gene in the battle against pancreatic cancer. New research involving K17 as a therapeutic target against this lethal disease is being conducted by Kenneth Shroyer, MD, PhD, the Marvin Kuschner Professor and Chair of Pathology at Stony Brook Medicine, and Luisa Escobar-Hoyos, PhD, Assistant Professor and Co-Director of the Pathology Translational Research Lab. The Pancreatic Cancer Action Network (PanCAN) awarded Drs. Shroyer and Escobar-Hoyas a $500,000 grant to carry out this research. This is the first time a PanCAN grant has been awarded to Stony Brook University. The two-year award will begin July 1, 2018.

The need for continued research funding for pancreatic cancer is urgent, as patients with pancreatic cancer have the lowest five-year survival rate of any major cancer—at just eight percent. According to data from PanCAN, pancreatic cancer is projected to become the second leading cause of cancer-related death in the United States by 2020.

Drs. Shroyer, Escobar-Hoyos, and members of their team have focused on the discovery and investigation of how K17 drives cancer aggression over the past seven years. These ongoing studies are based on their discoveries that led to the recognition that K17 impacts fundamental properties of tumor cells, including regulation of nuclear proteins that control cell division and mediate resistance to cancer chemotherapeutic agents. For more on this research, see this press release about a paper that shows the K17 protein promotes cancer

Going forward and under the translational research award, Drs. Shroyer, Escobar-Hoyos and colleagues will conduct a wide range of studies that could further establish K17 as an actionable target for the treatment of pancreatic ductal adenocarcinoma. Following the opening of the Medical and Research Translation (MART) Building, they will integrate their focus on the effects of K17 expression on cancer cell metabolism, in collaboration with other members of the Cancer Center and the Department of Biomedical Informatics.

According to Dr. Shroyer, If successful, the K17 investigation proposed in their PanCAN-supported study will be instrumental in uncovering an “Achilles’ heel” that underlies the most aggressive form of pancreatic cancer and will uncover new ways to treat this disease and extend patient survival.

Drs. Shroyer and Escobar-Hoyos and their team of collaborators and trainees were selected for this award through a competitive peer review process. The PanCAN Translational Research Award was established in 2014 and to date, 17 national grants have been conferred, including six in 2018. This program supports independent investigators conducting translational research that has as its endpoints, the development of novel and more effective approaches for the prevention, detection, and treatment of pancreatic cancer. 

For more about the 2018 PanCAN research grant recipients, see this news.

 

About Stony Brook University 

Stony Brook University is going beyond the expectations of what today’s public universities can accomplish. Since its founding in 1957, this young university has grown to become a flagship as one of only four University Center campuses in the State University of New York (SUNY) system with more than 26,000 students and 2,600 faculty members, and 18 NCAA Division I athletic programs. Our faculty have earned numerous prestigious awards, including the Nobel Prize, Pulitzer Prize, Indianapolis Prize for animal conservation, Abel Prize and the inaugural Breakthrough Prize in Mathematics. The University offers students an elite education with an outstanding return on investment: U.S. News & World Report ranks Stony Brook among the top 50 public universities in the nation. Its membership in the Association of American Universities (AAU) places Stony Brook among the top 62 research institutions in North America. As part of the management team of Brookhaven National Laboratory, the University joins a prestigious group of universities that have a role in running federal R&D labs. Stony Brook University is a driving force in the region’s economy, generating nearly 60,000 jobs and an annual economic impact of more than $4.6 billion. Our state, country and world demand ambitious ideas, imaginative solutions and exceptional leadership to forge a better future for all. The students, alumni, researchers and faculty of Stony Brook University are prepared to meet this challenge.

Related Posts

Archives

SBU on Instagram